Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients

• Status: Completed
• Trial end date: 2008-06-01

Summary

This is an exploratory study to evaluate the impact of eliminating steroid administration upon viral HCV load at 12 months measured by quantitative serum HCV-RNA determination in patients transplanted for HCV cirrhosis.

• Phase: Phase 2

Details

• Lead Sponsor: Astellas Pharma Inc
• Treatments: Antibodies; Immunoglobulins; Tacrolimus